BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16529343)

  • 1. The pharmacist as physician extender in family medicine office practice.
    Nichol A; Downs GE
    J Am Pharm Assoc (2003); 2006; 46(1):77-83. PubMed ID: 16529343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Providing pharmaceutical care in a physician office.
    Campbell RK; Saulie BA
    J Am Pharm Assoc (Wash); 1998; 38(4):495-9. PubMed ID: 9707960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Financial implications of pharmacist-led Medicare annual wellness visits.
    Park I; Sutherland SE; Ray L; Wilson CG
    J Am Pharm Assoc (2003); 2014; 54(4):435-40. PubMed ID: 25063264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community pharmacist-delivered Medicare Annual Wellness Visits within a family medicine practice.
    Evans TA; Fabel PH; Ziegler B
    J Am Pharm Assoc (2003); 2017; 57(3S):S247-S251. PubMed ID: 28400254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Billing for pharmacists' cognitive services in physicians' offices: multiple methods of reimbursement.
    Scott MA; Hitch WJ; Wilson CG; Lugo AM
    J Am Pharm Assoc (2003); 2012; 52(2):175-80. PubMed ID: 22370380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of 4 years of clinical pharmacist anticoagulation case management in a rural, private physician office.
    Ernst ME; Brandt KB
    J Am Pharm Assoc (2003); 2003; 43(5):630-6. PubMed ID: 14626756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacist-provided immunization compensation and recognition: white paper summarizing APhA/AMCP stakeholder meeting.
    Skelton JB; ;
    J Am Pharm Assoc (2003); 2011; 51(6):704-12. PubMed ID: 22068191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a pharmacist-run antiarrhythmic clinic in an ambulatory practice.
    Lifer SM; Musser MR; Kier KL
    J Am Pharm Assoc (2003); 2015; 55(5):546-51. PubMed ID: 26208334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacist integration into the medical home: qualitative analysis.
    Kozminski M; Busby R; McGivney MS; Klatt PM; Hackett SR; Merenstein JH
    J Am Pharm Assoc (2003); 2011; 51(2):173-83. PubMed ID: 21382807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of pharmacists into a patient-centered medical home.
    Scott MA; Hitch B; Ray L; Colvin G
    J Am Pharm Assoc (2003); 2011; 51(2):161-6. PubMed ID: 21382805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
    Wibowo Y; Parsons R; Sunderland B; Hughes J
    Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and implementation of a pharmacist-delivered Medicare annual wellness visit at a family practice office.
    Thomas MH; Goode JV
    J Am Pharm Assoc (2003); 2014; 54(4):427-34. PubMed ID: 25063263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reimbursement model for pharmacist-directed medication therapy management.
    Lloyd KB; Evans RL
    J Am Pharm Assoc (2003); 2012; 52(2):161-9. PubMed ID: 22370378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacy services in family practice: cost-benefit analysis. II. Referrals, appointment compliance, and costs.
    Chrischilles EA; Helling DK; Rowland CR
    Drug Intell Clin Pharm; 1984 May; 18(5):436-41. PubMed ID: 6426919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pay-for-performance model of medication therapy management in pharmacy practice.
    Lenz TL; Monaghan MS
    J Am Pharm Assoc (2003); 2011; 51(3):425-31. PubMed ID: 21555297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of pharmacists into patient-centered medical homes in federally qualified health centers in Texas.
    Wong SL; Barner JC; Sucic K; Nguyen M; Rascati KL
    J Am Pharm Assoc (2003); 2017; 57(3):375-381. PubMed ID: 28506398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Financial performance and reimbursement of pharmacist-led chronic care management.
    Martin R; Tram K; Le L; Simmons C
    Am J Health Syst Pharm; 2020 Nov; 77(23):1973-1979. PubMed ID: 32995845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacist compensation for cognitive services: focus on the physician office and community pharmacy.
    Snella KA; Trewyn RR; Hansen LB; Bradberry JC
    Pharmacotherapy; 2004 Mar; 24(3):372-88. PubMed ID: 15040651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collaborative drug therapy management services and reimbursement in a family medicine clinic.
    Kuo GM; Buckley TE; Fitzsimmons DS; Steinbauer JR
    Am J Health Syst Pharm; 2004 Feb; 61(4):343-54. PubMed ID: 15011762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impacts of a pharmacist-managed outpatient clinic and chemotherapy-directed electronic order sets for monitoring oral chemotherapy.
    Battis B; Clifford L; Huq M; Pejoro E; Mambourg S
    J Oncol Pharm Pract; 2017 Dec; 23(8):582-590. PubMed ID: 27733666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.